Founded in 2020, Altius Pharma Group was built to solve a fundamental gap: connecting world-class pharmaceutical manufacturers with the patients who need their products most.
Too many effective pharmaceutical products never reach the markets where they are needed most. Regulatory complexity, distribution challenges, and limited local knowledge create barriers that leave millions without access to treatments that are widely available elsewhere.
Altius Pharma Group exists to eliminate those barriers. We provide the regulatory expertise, distribution infrastructure, and commercial strategy that enables manufacturers to enter Latin American and African markets efficiently, compliantly, and profitably.
From a single office in Vicenza to 18+ markets in two continents.
Our values are not aspirational statements. They are operational commitments that guide how we serve manufacturers, regulators, and patients.
Every product registration, every dossier, every submission meets or exceeds the standards set by national health authorities. We never cut corners on compliance.
We begin with the market need, not the product. Understanding local healthcare systems, prescriber behavior, and patient demographics is the foundation of every strategy.
We build multi-year relationships with manufacturers and local distributors. Our success is measured not by deals signed, but by products reaching patients consistently.
Our partners receive clear reporting on registration status, market performance, and competitive dynamics. No hidden agendas, no information asymmetries.
From cold chain logistics to pharmacovigilance reporting, we maintain the same quality standards regardless of the market. GMP and GDP compliance are non-negotiable.
Altius Pharma Group established in Vicenza, Italy, with a focus on connecting European pharmaceutical manufacturers with Latin American markets.
Completed initial product registrations in Brazil and Mexico. Established partnerships with local regulatory consultants across 6 countries.
Extended operations to Sub-Saharan Africa. Secured distribution agreements covering Kenya, Nigeria, and South Africa. Opened partnerships with WHO-prequalified manufacturers.
Reached 10+ manufacturer partnerships. Portfolio expanded to include critical care, oncology, and anti-infective therapeutic areas. Facilitated first government tender wins.
Deepened focus on anesthesia, critical care, and emergency medicine. Established presence in 15+ markets with active product registrations.
Expanding into new therapeutic areas and geographies. Building dedicated market access capabilities for opioid crisis interventions and public health emergency products.
At the heart of European pharma manufacturing, with direct access to global trade routes.
Our headquarters in Vicenza, in the heart of the Veneto region, positions us at the crossroads of European pharmaceutical manufacturing and international trade routes.
Direct access to Italian and European pharmaceutical manufacturing clusters.
Proximity to major ports (Venice, Trieste) and international airports for efficient global shipping.
EU-based operations provide credibility and regulatory alignment for international pharmaceutical trade.
Whether you are a manufacturer seeking distribution or a healthcare organization looking for quality pharmaceutical products, our team is ready to help.
Start the Conversation